Hb-based nanoliposome with loaded DOX showed efficiency inducing the reversal of tumor hypoxia, increasing the uptake of the DOX into tumor cells, and inducing a significantly increased toxicity of the drug against tumor cells (Yang J. et al., 2018). The gene discussed is GSTM1; the disease is neoplasm.